R-Pharm

NCT07435324

Phase 3, Completed, 2024, 161 people, 27 Feb 2026, clinicaltrials.gov

NCT07435311

Phase 1, Completed, 2020, 118 people, 27 Feb 2026, clinicaltrials.gov

NCT03537404

Phase 1, Completed, 2017, 36 people, 25 May 2018, clinicaltrials.gov

NCT02248961

Phase 3, Completed, 2014, 179 people, 25 Sept 2014, clinicaltrials.gov

NCT00883116

Phase 3, Terminated, 2009, 551 people, 17 Apr 2009, clinicaltrials.gov

NCT00832117

Phase 1, Completed, 2009, 30 people, 29 Jan 2009, clinicaltrials.gov